back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-03-27 19:20 Tx date 2024-03-27 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$57,689
+6,631 vol $8.70 each |
56,254 | |
| Filed 2024-03-20 09:08 Tx date 2024-03-19 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$31,246
+3,676 vol $8.50 each |
49,623 | |
| Filed 2024-03-20 09:07 Tx date 2024-03-19 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-7,352 vol |
45,947 | |
| Filed 2024-03-19 09:40 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,509
+454 vol $7.73 each |
53,299 | |
| Filed 2024-03-19 09:39 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$28,582
+3,688 vol $7.75 each |
52,845 | |
| Filed 2023-03-31 18:40 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+7,430 vol |
49,157 | |
| Filed 2023-03-31 18:39 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$47,047
+6,273 vol $7.50 each |
41,727 | |
| Filed 2023-03-31 18:37 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-12,546 vol |
35,454 | |
| Filed 2023-03-22 12:25 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,016
+143 vol $7.11 each |
48,000 | |
| Filed 2023-03-22 12:23 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$24,243
+2,993 vol $8.10 each |
47,857 | |
| Filed 2022-04-01 16:56 Tx date 2022-03-31 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$53,603
+5,897 vol $9.09 each |
44,864 | |
| Filed 2022-03-15 18:33 Tx date 2021-12-31 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$17,270
+2,240 vol $7.71 each |
38,967 | |
| Filed 2021-03-23 08:50 Tx date 2021-03-19 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$52,005
+7,124 vol $7.30 each |
36,727 | |
| Filed 2021-03-11 14:48 Tx date 2020-12-31 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,607
+950 vol $4.85 each |
29,603 | |
| Filed 2020-04-03 08:45 Tx date 2020-03-31 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+12,408 vol |
28,653 | |
| Filed 2020-03-23 09:39 Tx date 2019-03-19 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$39,250
+4,775 vol $8.22 each |
10,649 | |
| Filed 2020-03-23 09:31 Tx date 2020-03-20 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,925
+2,500 vol $3.57 each |
16,245 | |
| Filed 2019-03-22 15:21 Tx date 2019-03-19 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$39,250
+4,775 vol $8.22 each |
||
| Filed 2020-03-02 10:14 Tx date 2020-01-31 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$11,422
+1,552 vol $7.36 each |
18,520 | |
| Filed 2019-03-28 Tx date 2019-03-28 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$90,021
+11,955 vol $7.53 each |
16,968 | |
| Filed 2019-03-22 Tx date 2019-03-19 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$39,250
+4,775 vol $8.22 each |
5,013 | |
| Filed 2019-03-07 Tx date 2018-09-10 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-03-07 Tx date 2018-09-10 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
238 | ||
| Filed 2018-09-13 Tx date 2018-09-10 |
$RX
BioSyent Inc. |
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
00 - Opening Balance-Initial SEDI Report
|
5,874 |